Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022

Detalles Bibliográficos
Autores principales: Stadelman, Anna M, Davis, Elizabeth, Ross, Colleen, Smelser, Chad, Sosin, Daniel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Rapid Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287845/
https://www.ncbi.nlm.nih.gov/pubmed/35853586
http://dx.doi.org/10.1016/j.annepidem.2022.07.004
_version_ 1784748337492131840
author Stadelman, Anna M
Davis, Elizabeth
Ross, Colleen
Smelser, Chad
Sosin, Daniel M
author_facet Stadelman, Anna M
Davis, Elizabeth
Ross, Colleen
Smelser, Chad
Sosin, Daniel M
author_sort Stadelman, Anna M
collection PubMed
description
format Online
Article
Text
id pubmed-9287845
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92878452022-07-18 Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022 Stadelman, Anna M Davis, Elizabeth Ross, Colleen Smelser, Chad Sosin, Daniel M Ann Epidemiol Rapid Report Elsevier 2022-10 2022-07-16 /pmc/articles/PMC9287845/ /pubmed/35853586 http://dx.doi.org/10.1016/j.annepidem.2022.07.004 Text en Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Rapid Report
Stadelman, Anna M
Davis, Elizabeth
Ross, Colleen
Smelser, Chad
Sosin, Daniel M
Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022
title Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022
title_full Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022
title_fullStr Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022
title_full_unstemmed Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022
title_short Assessing methods of calculating percent positivity in SARS-CoV-2 antigen and nucleic acid amplification test results — New Mexico, 2022
title_sort assessing methods of calculating percent positivity in sars-cov-2 antigen and nucleic acid amplification test results — new mexico, 2022
topic Rapid Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287845/
https://www.ncbi.nlm.nih.gov/pubmed/35853586
http://dx.doi.org/10.1016/j.annepidem.2022.07.004
work_keys_str_mv AT stadelmanannam assessingmethodsofcalculatingpercentpositivityinsarscov2antigenandnucleicacidamplificationtestresultsnewmexico2022
AT daviselizabeth assessingmethodsofcalculatingpercentpositivityinsarscov2antigenandnucleicacidamplificationtestresultsnewmexico2022
AT rosscolleen assessingmethodsofcalculatingpercentpositivityinsarscov2antigenandnucleicacidamplificationtestresultsnewmexico2022
AT smelserchad assessingmethodsofcalculatingpercentpositivityinsarscov2antigenandnucleicacidamplificationtestresultsnewmexico2022
AT sosindanielm assessingmethodsofcalculatingpercentpositivityinsarscov2antigenandnucleicacidamplificationtestresultsnewmexico2022

Ejemplares similares